4301 Connecticut Ave NW, Washington, DC 20008 4301 Hawthorne St NW, Washington, DC 20016 2022378508
Rachel Nugent Systems Support Manager
Population Action Int Social Services · Specialty Outpatient Clinic
1300 19 St NW, Washington, DC 20036 2025573400
Rachel Nugent Director Information Technology, Technical Director
Population Reference Bureau Think Tanks · Noncommercial Research Organization · Economic Research & Analysis · Other Social Advocacy Organizations
1875 Connecticut Ave NW SUITE 520, Washington, DC 20009 1875 Conn Ave NW, Washington, DC 20009 1337 Connecticut Ave NW, Washington, DC 20036 2024831100, 2023283937, 8008779881, 2026590411
Rachel A. Nugent
Family Health International Noncommercial Research Organization · Noncommercial Research Organizations, Nsk · Health/Allied Services
4401 Wilson Blvd, Arlington, VA 22203 2101 Wilson Blvd, Arlington, VA 22201 1825 Connecticut Ave NW, Washington, DC 20009 7035169779, 7035169781
Rachel Nugent Deputy Director, Blogger
Center for Global Development Think Tanks · Commercial Nonphysical Research · Other Social Advocacy Organizations
2055 L St Nw, 5, Washington 20036 1776 Massachusetts Ave NW, Washington, DC 20036 1800 Massachusetts Ave NW, Washington, DC 20036 2055 L St NW, Washington, DC 20036 2024160700
Us Patents
Method And Medicament For Treating Airway And/Or Lung Diseases
The present invention relates to a method and a medicament for airway and/or lung diseases such as moderate and/or severe asthma disease, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), and systemic sclerosis. The medicament contains an agent which inhibits TL1A-DR3 interaction, and the method involves administering an effective amount of the agent to a subject to inhibit at least one symptom, feature or condition selected from hyperplasia of epithelial cells, epithelial metaplasia, hypertrophy of smooth muscle cells, and hyperproliferation of smooth muscle cells, production of extracellular matrix, and/or airway and/or lung tissue remodeling.